The main differences between bipolar 1 and bipolar 2 are the severity of manic episodes, and whether or not someone experiences depression.
bpHope on MSN
Bipolar Disorder Symptoms — Diagnosis to Daily Life
Understanding bipolar disorder goes beyond its diagnostic checklist to the everyday symptoms that shape each individual’s ...
Upon being diagnosed with bipolar 1 disorder at the age of 24, Charlotte, a budding singer-songwriter, wasn't particularly angry, upset, or surprised. Her first thought after hearing the news? That ...
Bipolar disorder is a mental health condition that is characterized by dramatic mood episodes that include mania or hypomania. These “high” moods alternate with periods of depression. People who ...
Iloperidone (Fanapt) is now FDA-approved for adults with bipolar 1 disorder who are experiencing manic or mixed episodes (mania plus depression). The drug was already approved as a treatment for ...
bpHope on MSN
Finding the Benefits of Bipolar Disorder
Exploring the upsides of their bipolar diagnosis has helped many people turn their uniqueness into pillars of personal ...
Vanda Pharmaceuticals announces the FDA approval of iloperidone (Fanapt) for the acute treatment of bipolar 1 disorder. Iloperidone is a second-generation atypical antipsychotic agent for managing ...
May 19 -- MONDAY, May 18 (HealthDay News) -- The Janssen Pharmaceuticals drug Risperdal Consta (risperidone) has been approved by the U.S. Food and Drug Administration for people with Bipolar 1 ...
Please provide your email address to receive an email when new articles are posted on . Bipolar disorder and postpartum symptoms often overlap among women, leading to bipolar 1 being underdiagnosed. A ...
Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to print (Opens in new window) (BPT) – The ...
September 14, 2010 — Merck has announced that its antipsychotic asenapine (Saphris), in sublingual dissolving tablet form, has been approved for expanded use by the US Food and Drug Administration ...
An antipsychotic approved by the FDA in 2009 to treat schizophrenia has now been green-lighted for use in bipolar 1 disorder. Iloperidone (Fanapt) is now FDA-approved for adults with bipolar 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results